Oncology
Larry Anderson, M.D. , PHD
Professor of Internal Medicine; Director, Myeloma, Waldenström's, and Amyloidosis Program; Co-Director, Phase I Clinical Trial Research Program and Cellular Immunotherapy and Autologous Stem Cell Transplant Program
Dr. Larry Anderson Jr. is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Hematology and Oncology. He is the only oncologist in North Texas to exclusively treat plasma cell cancers and serves as Director of the Myeloma, Waldenström's, and Amyloidosis Program at the Harold C. Simmons Comprehensive Cancer Center. He also leads the Hematologic Malignancies and Cellular Therapy Clinical Research Program and co-directs the Phase I C
25+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (ABIM)
- Medical Oncology (ABIM Subspecialty Board)
Education & Training
- UT Health Science Center McGovern Medical School — M.D. (2000)
- Doctoral degree in Cancer Immunology — UT Graduate School of Biomedical Sciences at Houston and MD Anderson Cancer Center
- Internship, Internal Medicine — Mayo Clinic (2003)
- Fellowship, Medical Oncology — Fred Hutchinson Cancer Research Center (2006)
Peer Recognition
- D Magazine — Best Doctor
2021-2025 (5 years)
- Texas Monthly — Super Doctor
2018-2025 (8 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- UT Southwestern Medical Center
- Harold C. Simmons Comprehensive Cancer Center
Languages
English
Experience
25+ years in practice